Oppenheimer lifts Marvell target to $325; Outperform kept
Oppenheimer raised its Marvell price target to $325 from $300 and kept an Outperform rating after upside Q2 results and a Q3 outlook led by DCAI.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.